<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>aaemonline.org Blog &#187; Tamiflu</title>
	<atom:link href="http://aaemonline.org/blog/index.php/category/influenza/tamiflu/feed/" rel="self" type="application/rss+xml" />
	<link>http://aaemonline.org/blog</link>
	<description>Your Health and the Environment</description>
	<lastBuildDate>Mon, 09 Feb 2009 22:21:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Influenza Drug Labels Get Warnings for Neuropsychiatric Changes</title>
		<link>http://aaemonline.org/blog/2009/01/26/influenza-drug-labels-get-warnings-for-neuropsychiatric-changes/</link>
		<comments>http://aaemonline.org/blog/2009/01/26/influenza-drug-labels-get-warnings-for-neuropsychiatric-changes/#comments</comments>
		<pubDate>Mon, 26 Jan 2009 18:36:44 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Relenza]]></category>
		<category><![CDATA[Tamiflu]]></category>
		<category><![CDATA[Medscape Medical News]]></category>

		<guid isPermaLink="false">http://aaemonline.org/blog/?p=19</guid>
		<description><![CDATA[
FDA says some chemicals cause neuropsychiatric changes
Recalls and Warnings Influenza Drug Labels Get Warnings for Neuropsychiatric Changes Patients with influenza should be closely monitored for signs of abnormal behavior during treatment with Tamiflu and possibly also Relenza. (US Food and Drug Administration.)
Medscape Medical News
http://www.medscape.com/viewarticle/570996?sssdmh=dm1.339468&#038;src=nldne
]]></description>
			<content:encoded><![CDATA[<p>
FDA says some chemicals cause neuropsychiatric changes</p>
<p>Recalls and Warnings Influenza Drug Labels Get Warnings for Neuropsychiatric Changes Patients with influenza should be closely monitored for signs of abnormal behavior during treatment with Tamiflu and possibly also Relenza. (US Food and Drug Administration.)</p>
<p>Medscape Medical News<br />
http://www.medscape.com/viewarticle/570996?sssdmh=dm1.339468&#038;src=nldne</p>
]]></content:encoded>
			<wfw:commentRss>http://aaemonline.org/blog/2009/01/26/influenza-drug-labels-get-warnings-for-neuropsychiatric-changes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.239 seconds -->

